|
Subscribe to: Heart Care Info RSS Feed
Heart Care Info - Heart Disease Prevention & Treatment | |||||||||||||||
| |||||||||||||||
![]() IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis
T Yamashita, T Iwakura... - Cardiovascular ..., 2011 - Aims Interleukin (IL)-17-producing helper T (Th17) cells have been proposed to participate in the pathogenesis of chronic inflammation, such as autoimmune myocarditis. IL-6 gene ablation confers the resistance to experimental autoimmune myocarditis (EAM). In this ... Methods and results To induce EAM, mice were immunized twice with α-myosin heavy chain peptide. Three weeks after the first injection, the cardiac expression of the Th17-specific transcription factor, retinoic acid receptor-related orphan nuclear receptor (ROR γt), was up-regulated. Consistently, Th17 cells were recruited into EAM hearts, as analysed by flow cytometry. Using the mice with enhanced green fluorescence protein (e GFP) gene knocked-in at RORγt locus (RORγt-e GFP mice), we observed Th17 cell infiltration into inflamed lesions. Pre-treatment with IL-6 receptor (IL-6R)-blocking antibody (anti-IL-6R Ab) inhibited EAM induction in terms of disease severity score (3.5 ± 0.8; Ig G vs. 0.5 ± 0.8; anti-IL-6R Ab, n = 6, P< 0.01) and suppressed the myocardial expression of IL-17 and RORγt. In contrast, the administration of anti-IL-6R Ab 7 days after the first immunization failed to show the inhibitory effects, suggesting that IL-6 plays important roles in EAM initiation. Finally, by generating RORγt-e GFP homozygous mice, we revealed that RORγt gene ablation conferred the resistance to EAM induction. More Details:IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis |
|
||||||||||||||